Fibrillex: Began Phase II/III study

Neurochem Inc. (TSE:NRM), Saint-Laurent, Quebec
Product: Fibrillex
Business: Metabolic, Renal
Therapeutic category: Matrix

Read the full 136 word article

How to gain access

Continue reading with a
two-week free trial.